UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Recent progress of fluorescent probes for the detection of alkaline phosphatase (ALP): A review

Dyes and pigments, 2021-10, Vol.194, p.109569, Article 109569

2021

Volltextzugriff (PDF)

A novel near-infrared fluorescent probe for visualization of intracellular hydrogen peroxide

Frontiers in chemistry, 2022-10, Vol.10, p.1025723-1025723

2022

Volltextzugriff (PDF)

A ratiometric fluorescent probe based on a novel fluorophore with high selectivity for imaging cysteine in living cells

Luminescence (Chichester, England), 2024-06, Vol.39 (6), p.e4806-n/a

2024

Volltextzugriff (PDF)

A near‐infrared fluorescent probe for detecting hydrazine metabolized from isoniazid in living cells

Luminescence (Chichester, England), 2024-01, Vol.39 (1), p.e4676-n/a

2024

Volltextzugriff (PDF)

Synthesis and Photophysical Characterization of a Photoaffinity Molecular Switch

International journal of sciences, 2023, Vol.12 (8), p.28-31

2023

Volltextzugriff (PDF)

The Co/CoNi sequential configurations based on transparent basalt substrates toward excellent microwave absorption

Chemical engineering journal (Lausanne, Switzerland : 1996), 2024-02, Vol.481, p.148207, Article 148207

2024

Volltextzugriff (PDF)

Influences of Electromagnetic Energy on Bio-Energy Transport through Protein Molecules in Living Systems and Its Experimental Evidence

International journal of molecular sciences, 2016-08, Vol.17 (8), p.1130-1130

2016

Volltextzugriff (PDF)

Neoadjuvant–adjuvant pertuzumab in HER2-positive early breast cancer: final analysis of the randomized phase III PEONY trial

Nature communications, 2024-03, Vol.15 (1), p.2153-2153, Article 2153

2024

Volltextzugriff (PDF)

Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III Trial

Journal of clinical oncology, 2020-06, Vol.38 (16), p.1774-1784

2020

Volltextzugriff (PDF)

Efficacy, Safety, and Tolerability of Pertuzumab, Trastuzumab, and Docetaxel for Patients With Early or Locally Advanced ERBB2-Positive Breast Cancer in Asia: The PEONY Phase 3 Randomized Clinical Trial

JAMA oncology, 2020-03, Vol.6 (3), p.e193692

2020

Volltextzugriff (PDF)

Abstract GS1-08: Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for triple-negative breast cancer (cbcsg010): An open-label, randomised, multicentre, phase 3 trial

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.GS1-08-GS1-08

2020

Volltextzugriff (PDF)

Efficacy and safety analysis of trastuzumab and paclitaxel based regimen plus carboplatin or epirubicin as neoadjuvant therapy for clinical stage II-III, HER2-positive breast cancer patients: a phase 2, open-label, multicenter, randomized trial

Oncotarget, 2015-07, Vol.6 (21), p.18683-18692

2015

Volltextzugriff (PDF)

Abstract PD18-03: Final analysis of the Phase III PEONY trial: long-term efficacy and safety of neoadjuvant–adjuvant pertuzumab or placebo, plus trastuzumab and docetaxel, in patients with HER2-positive early or locally advanced breast cancer

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.PD18-03-PD18-03

2023

Volltextzugriff (PDF)

Cbcsg-10: Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for triple negative breast cancer

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.1012-1012

2016

Volltextzugriff (PDF)

National consensus in China on diagnosis and treatment of patients with advanced breast cancer

Annals of translational medicine, 2015-10, Vol.3 (17), p.242-242

2015

Volltextzugriff (PDF)

Modelling abnormal temperature increases on composite insulators and influencing factors

2024 IEEE International Conference on High Voltage Engineering and Applications (ICHVE), 2024, p.1-5

2024

Volltextzugriff (PDF)

1 – 16 von 16

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(12)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(15)
Tagungsberichte
(1)

Sprache

Englisch
(16)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Recent progress of fluorescent probes for the detection of alkaline phosphatase (ALP): A review

A novel near-infrared fluorescent probe for visualization of intracellular hydrogen peroxide

A ratiometric fluorescent probe based on a novel fluorophore with high selectivity for imaging cysteine in living cells

A near‐infrared fluorescent probe for detecting hydrazine metabolized from isoniazid in living cells

Synthesis and Photophysical Characterization of a Photoaffinity Molecular Switch

The Co/CoNi sequential configurations based on transparent basalt substrates toward excellent microwave absorption

Influences of Electromagnetic Energy on Bio-Energy Transport through Protein Molecules in Living Systems and Its Experimental Evidence

Neoadjuvant–adjuvant pertuzumab in HER2-positive early breast cancer: final analysis of the randomized phase III PEONY trial

Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III Trial

Efficacy, Safety, and Tolerability of Pertuzumab, Trastuzumab, and Docetaxel for Patients With Early or Locally Advanced ERBB2-Positive Breast Cancer in Asia: The PEONY Phase 3 Randomized Clinical Trial

Abstract GS1-08: Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for triple-negative breast cancer (cbcsg010): An open-label, randomised, multicentre, phase 3 trial

Efficacy and safety analysis of trastuzumab and paclitaxel based regimen plus carboplatin or epirubicin as neoadjuvant therapy for clinical stage II-III, HER2-positive breast cancer patients: a phase 2, open-label, multicenter, randomized trial

Abstract PD18-03: Final analysis of the Phase III PEONY trial: long-term efficacy and safety of neoadjuvant–adjuvant pertuzumab or placebo, plus trastuzumab and docetaxel, in patients with HER2-positive early or locally advanced breast cancer

Cbcsg-10: Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for triple negative breast cancer

National consensus in China on diagnosis and treatment of patients with advanced breast cancer

Modelling abnormal temperature increases on composite insulators and influencing factors

Suchergebnisse filtern